Antidepressant and anxiolytic consumption during COVID-19 pandemic-Reference-Cited by-同舟云学术

Antidepressant and anxiolytic consumption during COVID-19 pandemic

Published:2022-12-31 Issue:03 Volume:68 Page:477-478
ISSN:1857-8969
Container-title:Macedonian Pharmaceutical Bulletin
language:en
Short-container-title:Maced. Pharm. Bull.

Author:

Dimkovikj Dragana¹,Gigopulu Olga²,Naumovska Zorica³,Sterjev Zoran³

Affiliation:

1. Pharmacy Adonis-Farm, III MUB 5/4, 1300 Kumanovo, North Macedonia

2. Institute so Applied Chemistry and Pharmaceutical Analysis, Faculty of Pharmacy, University “Ss. Cyril and Methoduis”, Majka Tereza 47, 1000 Skopje, Republic of N. Macedonia

3. Institute of Pharmaceutical chemistry, Faculty of Pharmacy, University “Ss. Cyril and Methoduis”, Majka Tereza 47, 1000 Skopje, Republic of N. Macedonia

Publisher

Macedonian Pharmaceutical Association

Subject

General Medicine

Link

https://bulletin.mfd.org.mk/volumes/Volume%2068_3/68_3_229.pdf

Reference4 articles.

1. Person, B., Sy, F., Holton, K., Govert, B., Liang, A., Garza, B., et al., 2004. Fear and Stigma: The Epidemic within the SARS Outbreak. Emerg Infect Dis. 10(2), 358-363. https://doi.org/10.3201/eid1002.030750

2. Shultz, J.M., Cooper, J.L., Baingana, F. et al., 2016. The Role of Fear-Related Behaviors in the 2013–2016 West Africa Ebola Virus Disease Outbreak. Curr Psychiatry Rep. 18, 104. https://doi.org/10.1007/s11920-016-0741-y

3. World Health Organization (WHO). 2022. COVID-19 pandemic triggers 25% increase in prevalence of anxiety and depression worldwide [Internet]. [cited 2022 Jun 3]. Available from: https://www.who.int/news/item/02-03-2022-covid-19-pandemic-triggers-25-increase-in-prevalence-of-anxiety-and-depression-worldwide

4. World Health Organization (WHO). 2019. Mental health [Internet]. [cited 2022 Jun 3]. Available from: https://www.who.int/health-topics/mental-health